Our clinical analysis disclosed an association of circulating anti-Gal-8 antibodies with worse evolution in newly diagnosed and still untreated RRMS patients, showing EDSS worsening within the first year of follow up. Here, LGALS8 is linked to relapsing-remitting multiple sclerosis.